Trexquant Investment’s Cogent Biosciences COGT Stock Holding History

Trexquant Investment’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.14M	Buy	107,443 +51,337	+92%	+$1.9M	0.03%	727
2025 Q4	$1.99M	Sell	56,106 -510,266	-90%	-$14.3M	0.02%	993
2025 Q3	$8.13M	Buy	566,372 +65,329	+13%	+$774K	0.08%	366
2025 Q2	$3.6M	Buy	501,043 +317,222	+173%	+$1.76M	0.04%	654
2025 Q1	$1.1M	Sell	183,821 -93,702	-34%	-$735K	0.01%	1060
2024 Q4	$2.16M	Buy	277,523 +179,958	+184%	+$1.79M	0.03%	836
2024 Q3	$1.05M	Sell	97,565 -51,289	-34%	-$499K	0.01%	1035
2024 Q2	$1.25M	Buy	148,854 +130,001	+690%	+$986K	0.02%	925
2024 Q1	$127K	Sell	18,853 -58,549	-76%	-$362K	﹤0.01%	1378
2023 Q4	$455K	Buy	77,402 +36,294	+88%	+$278K	0.01%	1115
2023 Q3	$401K	Buy	+41,108	New	+$488K	0.01%	1113
2023 Q1	–	Sell	-61,506	Closed	-$711K	–	1478
2022 Q4	$711K	Buy	61,506 +23,904	+64%	+$296K	0.02%	775
2022 Q3	$561K	Buy	+37,602	New	+$515K	0.02%	763
2021 Q4	–	Sell	-11,407	Closed	-$96K	–	1346
2021 Q3	$96K	Buy	+11,407	New	+$87.4K	0.01%	1055
2021 Q1	–	Sell	-13,138	Closed	-$148K	–	1163
2020 Q4	$148K	Buy	+13,138	New	+$144K	0.02%	937

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Trexquant Investment's COGT Position: Q1 2026 in Review

Trexquant Investment increased its Cogent Biosciences (COGT) stake by 92% in Q1 2026, buying an estimated $1.9M and bringing the position to 107,443 shares worth $4.14M. The position accounts for 0.03% of the portfolio, ranked #727.

Trexquant Investment first reported a position in COGT in Q4 2020 and has held it in 15 quarters since. The position peaked at $8.13M in Q3 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Trexquant Investment held 107,443 shares of Cogent Biosciences worth $4.14M as of Q1 2026.
Trexquant Investment bought 51,337 Cogent Biosciences shares in Q1 2026, an estimated $1.9M.
Cogent Biosciences made up 0.03% of Trexquant Investment's portfolio in Q1 2026, its #727 holding.
Trexquant Investment first reported a position in Cogent Biosciences in Q4 2020 and has held it in 15 quarters since.
Trexquant Investment's Cogent Biosciences position peaked at $8.13M in Q3 2025.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.